These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

837 related items for PubMed ID: 16679277

  • 1. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A.
    Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
    Wang QJ, Wang Y, Xu X, Xiao H, Ma L.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
    [Abstract] [Full Text] [Related]

  • 3. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Huang B, Liang CH, Liu HJ, Wang GY, Zhang SX.
    Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
    [Abstract] [Full Text] [Related]

  • 4. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Knopp MV, Runge VM, Essig M, Hartman M, Jansen O, Kirchin MA, Moeller A, Seeberg AH, Lodemann KP.
    Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
    [Abstract] [Full Text] [Related]

  • 5. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P, Runge VM, Bücker A, Schürholz H, Reith W, Robert P, Jackson C, Lanz T, Schneider G.
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [Abstract] [Full Text] [Related]

  • 6. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU, Reiser MF, Huber AM.
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [Abstract] [Full Text] [Related]

  • 7. Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla.
    Bueltmann E, Erb G, Kirchin MA, Klose U, Naegele T.
    Invest Radiol; 2008 Oct; 43(10):695-702. PubMed ID: 18791411
    [Abstract] [Full Text] [Related]

  • 8. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV.
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [Abstract] [Full Text] [Related]

  • 9. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine.
    Knopp MV, Giesel FL, von Tengg-Kobligk H, Radeleff J, Requardt M, Kirchin MA, Hentrich HR.
    J Magn Reson Imaging; 2003 Jun; 17(6):694-702. PubMed ID: 12766899
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
    Kuhn MJ, Picozzi P, Maldjian JA, Schmalfuss IM, Maravilla KR, Bowen BC, Wippold FJ, Runge VM, Knopp MV, Wolansky LJ, Gustafsson L, Essig M, Anzalone N.
    J Neurosurg; 2007 Apr; 106(4):557-66. PubMed ID: 17432704
    [Abstract] [Full Text] [Related]

  • 11. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC, Inan N, Anik Y, Erturk MS, Ural D, Demirci A.
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [Abstract] [Full Text] [Related]

  • 12. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
    Runge VM, Biswas J, Wintersperger BJ, Baumann SS, Jackson CB, Herborn CU, Patel T.
    Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM, Ouyang H, Zhou CW.
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [Abstract] [Full Text] [Related]

  • 14. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB.
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
    Schneider G, Altmeyer K, Kirchin MA, Seidel R, Grazioli L, Morana G, Saini S.
    Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
    [Abstract] [Full Text] [Related]

  • 16. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
    Nural MS, Gokce E, Danaci M, Bayrak IK, Diren HB.
    Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
    [Abstract] [Full Text] [Related]

  • 17. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
    Colosimo C, Demaerel P, Tortori-Donati P, Christophe C, Van Buchem M, Högström B, Pirovano G, Shen N, Kirchin MA, Spinazzi A.
    Pediatr Radiol; 2005 May; 35(5):501-10. PubMed ID: 15678342
    [Abstract] [Full Text] [Related]

  • 18. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K, Breuckmann F, Hunold P, Barkhausen J, Schlosser T.
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [Abstract] [Full Text] [Related]

  • 19. Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio.
    Pediconi F, Fraioli F, Catalano C, Napoli A, Danti M, Francone M, Venditti F, Nardis P, Passariello R.
    Radiol Med; 2003 May; 106(1-2):87-93. PubMed ID: 12951555
    [Abstract] [Full Text] [Related]

  • 20. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, Merkle EM.
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.